Portada Articulos Originales
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding [ De Clínica ]( Pain. 2007 Dec 28. [Epub ahead of print] )
Chronic pain in patients with substance abuse disorder: general guidelines and an approach to treatment. [ De Clínica ]( Postgrad Med. 2008 Apr;120(1):75-9. ) |
|
|
Recomienda este area |
Si crees que este sitio puede interesar a algun compañero no dude en recomendarselo
Recomendar el sitio
|
|